Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 27, 2011	goldstein joseph l	Director	Automatic Sell	5,401	34.67
Feb 3, 2010	kolinski stuart	Officer	Automatic Sell	5,401	27.66 - 28.08
May 14, 2013	aberman michael s	Officer	Automatic Sell	5,529	278.72 - 281.72
Nov 23, 2010	goldstein joseph l	Director	Automatic Sell	5,669	29.81
Jan 9, 2013	powchik peter	Officer	Option Execute	5,752	16.80 - 21.25
Jan 14, 2011	roberts william	Officer	Automatic Sell	5,795	33.99 - 34.49
Dec 7, 2011	roberts william	Officer	Disposition (Non Open Market)	5,812	n/a
Feb 2, 2010	mccorkle douglas s	Officer	Automatic Sell	5,875	28.00
Feb 2, 2010	mccorkle douglas s	Officer	Option Execute	5,875	9.49 - 11.64
Apr 11, 2013	mccorkle douglas s	Officer	Option Execute	5,875	30.63
May 1, 2013	mccorkle douglas s	Officer	Option Execute	5,875	52.03
Feb 14, 2011	goldberg murray a	Officer	Automatic Sell	5,885	35.97 - 37.42
Dec 17, 2012	stahl neil	Officer	Option Execute	5,952	16.80
Dec 18, 2012	terifay robert j	Officer	Option Execute	5,952	16.80
Dec 23, 2008	gilman alfred g	Director	Acquisition (Non Open Market)	6,000	n/a
Dec 23, 2008	gilman alfred g	Director	Disposition (Non Open Market)	6,000	n/a
Mar 4, 2011	terifay robert j	Officer	Automatic Sell	6,099	38.00
Mar 4, 2011	terifay robert j	Officer	Option Execute	6,099	21.92
Jun 4, 2010	goldberg murray a	Officer	Automatic Sell	6,100	28.56 - 29.37
Dec 10, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	6,100	n/a
Showing 201-220 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.